Literature DB >> 17052537

Henoch-Schönlein purpura associated with malignancy in adults.

Joanna M Zurada1, Kimberley M Ward, Marc E Grossman.   

Abstract

Malignancy is a well-known cause of cutaneous vasculitis. The occurrence of neoplasia and Henoch-Schönlein purpura (HSP) is rare and poorly understood in adults. A total of 31 cases have been reported in the world literature of adult malignancy-associated HSP. Patients were overwhelmingly male (94%) with a mean age of 60 years and presented predominantly with solid tumors (61%). The most frequent tumors were lung (nonsmall-cell) (n = 8), multiple myeloma (n = 5), prostate (n = 5), and non-Hodgkin's lymphoma (n = 3). The majority of patients (55%) developed HSP within 1 month of cancer diagnosis or detection of metastases. We present 3 cases of adults who, in the absence of known precipitating factors, developed HSP within 2 months of diagnosis of a solid tumor or metastases. We recommend that adults, especially older men who present with unexplained HSP, be evaluated for occult neoplasm. We also advise that patients with a known history of malignancy who present with HSP be evaluated for metastatic disease.

Entities:  

Mesh:

Year:  2006        PMID: 17052537     DOI: 10.1016/j.jaad.2005.10.011

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  23 in total

Review 1.  Gastrointestinal manifestations of Henoch-Schonlein Purpura.

Authors:  Ellen C Ebert
Journal:  Dig Dis Sci       Date:  2008-03-20       Impact factor: 3.199

2.  The clinical implications of adult-onset henoch-schonelin purpura.

Authors:  Warit Jithpratuck; Yasmin Elshenawy; Hana Saleh; George Youngberg; David S Chi; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2011-05-27

3.  Clinicopathologic correlation of 282 leukocytoclastic vasculitis cases in a tertiary hospital: a focus on direct immunofluorescence findings at the blood vessel wall.

Authors:  Caroline Maris Takatu; Antonio Pedro Ribeiro Heringer; Valéria Aoki; Neusa Yuriko Sakai Valente; Paula Cristina de Faria Sanchez; Jozélio Freire de Carvalho; Paulo Ricardo Criado
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

4.  Henoch-Schönlein purpura associated with a neuroblastoma: Report of one case and a review of the literature.

Authors:  Qiaoli Dong; Shanshan Cao; Hongwen Zhang; Hui Geng
Journal:  Intractable Rare Dis Res       Date:  2012-11

5.  Concomitant association of giant cell arteritis and malignancy: a multicenter retrospective case-control study.

Authors:  S Deshayes; E Liozon; N Chanson; K Sacré; T Moulinet; C Blanchard-Delaunay; O Espitia; M Groh; M Versini; T Le Gallou; J-E Kahn; V Grobost; S Humbert; M Samson; R Mourot Cottet; K Mazodier; A Dartevel; J Campagne; A Dumont; B Bienvenu; M Lambert; A Daumas; D Saadoun; A Aouba; H de Boysson
Journal:  Clin Rheumatol       Date:  2019-01-07       Impact factor: 2.980

6.  Adult Onset Henoch-Schonlein Purpura associated with a Metastatic Malignancy of Unknown Primary Origin.

Authors:  Therese Posas-Mendoza; Dayna Lucuab-Fegurgur; Jefferson Roberts
Journal:  Hawaii J Med Public Health       Date:  2018-10

Review 7.  IgA Vasculitis in Adults: a Rare yet Challenging Disease.

Authors:  Kinanah Yaseen; Leal C Herlitz; Alexandra Villa-Forte
Journal:  Curr Rheumatol Rep       Date:  2021-07-01       Impact factor: 4.592

Review 8.  Urological Manifestations of Henoch-Schonlein Purpura: A Review.

Authors:  Amanda Dalpiaz; Richard Schwamb; Yimei Miao; Jacquelyn Gonka; Wayne Walzter; Sardar A Khan
Journal:  Curr Urol       Date:  2015-07-10

Review 9.  [Rheumatoid symptoms in patients with hematologic neoplasms].

Authors:  S Kleinert; P La Rosée; K Krüger
Journal:  Z Rheumatol       Date:  2017-10       Impact factor: 1.372

10.  Rectal Adenocarcinoma As An Uncommon Cause of Immunoglobulin A Vasculitis (Henoch-Schönlein Purpura).

Authors:  Ahmet Omma; Mehmet Emin Enecik; Zeynep Özbalkan; Sevinç Can Sandikçi; Yaşar Karaaslan
Journal:  Arch Rheumatol       Date:  2017-01-18       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.